Market Overview
Global Sleep Apnea Device Market is anticipated to exhibit a CAGR of 6.52% during the assessment period of 2020 to 2027, to surpass USD 7,683.72 Million by 2027. The global market growth is driven by technological advancements in sleep apnea devices. There are many lucrative opportunities for the major market players to develop advanced, safe, and comfortable products in the future.
The global Sleep Apnea devices market is expected to record significant market growth during the review period. The increasing incidences of sleep apnea and the growing geriatric population which leads to respiratory disorders are the major factors creating a huge demand for sleep apnea devices during the global market. According to the report published by ResMed at the American Thoracic Society (ATS) 2018 International Conference, OSA afflicted more than 936 million people worldwide in 2018, which is almost 836% more than the affected population in 2007. Therefore, the increasing number of people suffering from this disorder has resulted in a rising demand for sleep apnea diagnostic devices.

Market Segmentation
Global Sleep Apnea Device Market has been classified into Type and End User.
Based on the type segment, the global sleep apnea device market has been bifurcated into diagnostic and therapeutic devices. Diagnostic devices are further divided into polysomnography devices, home sleep testing devices, pulse oximeters, sleep screening devices. Polysomnography devices dominated the market in 2019.
Polysomnography devices are applicable to observe sleep stages and cycles to identify when sleep patterns are disrupted and why. The rising number of product advancements and launches is also fuelling the growth of this segment.
Regional Analysis
Geographically, the Global Sleep Apnea Device Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to drive the market during the review period owing to the largest market share in 2019. The regional market has been classified into North America and Latin America, with the North American market further bifurcated into the US and Canada. The regional market is driven by the increasing prevalence of Obstructive Sleep Apnea (OSA), rising patient adherence for positive airway pressure devices, and medical coverage for sleep apnea devices.
The European sleep apnea device market has been segmented into Western Europe and Eastern Europe. The increasing elderly population base prone to suffer from sleep disorders is expected to fuel the regional business growth.
Asia-Pacific has been classified into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to witness the fastest market growth potential over the review period owing to the rising per capita health spending, the emerging healthcare sector in China, India, and Australia, rising need for sleep apnea device such as continuous positive airway pressure (CPAP) machine used for the diagnosis of sleep disorders, and the increasing patient population suffering from sleep apnea.
Major Players
The Key Players in the Global Sleep Apnea Device Market are Koninklijke Philips (Netherlands), ResMed (US), LivaNova (UK), Compumedics (Australia), Nihon Kohden (Japan), GE Healthcare (US), Natus Medica (US), BMC Medical (China), Cadwell (US), and Curative Medical (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global Sleep Apnea Device Market Research Report—Forecast till 2027 first appeared on CRI Report.

The post Global Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027 first appeared on CRI Report.

Market Snapshot
According to Market Research Future analysis, the Global Phototherapy Market is anticipated to exhibit a 4.61% CAGR during the review period. As per the GBP analysis, skin disease is likely to be the leading cause of non-fatal disease burden worldwide. Skin diseases are more common in men than in women and increases with the age. The monetary weight of psoriasis is around USD 35 billion in the US each year, and treatment costs are ascending than general swelling. Light-radiating diode (LED) phototherapy addresses a practical, protected, solid, and compact psoriasis therapy. Also, it has benefits, including low force utilization, low warmth creation, and a longer life expectancy of the light-radiating unit when contrasted with other light sources.
Global Phototherapy Market is expected to witness a notable market expansion during the study period owing to the rising occurrence of severe skin diseases and the increasing number of preterm and low-weight births. Additionally, the increasing adoption of LED-based phototherapy equipment is also fuelling the growth of the market during the review period. However, the major restraining factor for the growth of the global market is differential awareness and availability between countries and issues in venture capital, start-ups, and collaborations during the forecast period.

Market Segmentation
The global phototherapy market has been classified into product, radiation, application, end-user, and region.
Based on product type, the global market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories. Based on the radiation segment, the global market has been divided into UVA, UVB, and UVC. Based on application type, the global phototherapy market has been segregated into skin disease treatment, neonatal jaundice management, and sterilization. In terms of the end-user segment, the global phototherapy market has been classified into hospital & clinic, dermatology center, and homecare.

Regional Analysis
Geographically, the phototherapy market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Americas is likely to drive the largest phototherapy market is expected to register a 4.63% CAGR during the forecast period owing to the highest market share of 42.60% in 2019. The regional market growth is attributed to the surging demand for skin treatments in the US and Canada. Furthermore, the growing adoption of home phototherapy is fuelling the regional market growth during the review period. Home phototherapy is more patient-friendly in terms of avoiding frequent hospital visits and it is the most cost-effective treatment option for patients with moderate-to-severe psoriasis. Therefore, the phototherapy market in the Americas is likely to exhibit a 4.63% CAGR during the assessment period.
Europe is expected to contribute the second-largest market for the global phototherapy market followed by Asia-Pacific during the review period.
Major Players
The Prominent Players in the report on the Global Phototherapy Market include Signify Holding (Netherlands), Atom Medical Corporation (Japan), National Biological Corporation (US), Solarc Systems Inc. (Canada), GE Healthcare (US), Natus Medical Incorporated (US), Herbert Waldmann GmbH & Co. KG (Germany), Phoenix Medical Systems (P) Ltd (India), The Daavlin Company (US), and Strata Skin Sciences, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Phototherapy Market Research Report—Forecast till 2027 first appeared on CRI Report.

Intracranial Hemorrhage Diagnosis & Treatment Market Overview

Global Intracranial Hemorrhage Diagnosis & Treatment Market is expected to witness a CAGR of 5.98% during the research period of 2020 to 2027. Intracranial hemorrhage is intense bleeding inside the skull or brain which results in a life-threatening emergency. lead to an increase in intracranial pressure, which can further damage brain tissues. The global market growth is mainly attributed to the rising prevalence of aneurysms, the growing number of road accidents, and the rising expenditure on healthcare infrastructure. Furthermore, the increased funding for the research and treatment of intracranial hemorrhage drives the growth of the market.

The Global Intracranial Hemorrhage Diagnosis & Treatment Market is anticipated to register a healthy market growth owing to the largest market value of USD 1,493.98 Million in 2019. Additionally, the geriatric population and age-related brain disorders also raise the number of patients in need of diagnostic tools required for assessing the types of hemorrhage. However, the rising availability of counterfeit drugs & complications associated with the surgery and lack of awareness about the available treatments is expected to restrain the growth of the global market during the review period.

Market Segmentation
Global Intracranial Hemorrhage Diagnosis & Treatment Market has been classified into Type and Diagnosis & Treatment.
Based on product segment, the market has been classified into an intracerebral hemorrhage, subarachnoid hemorrhage, epidural hematoma, and subdural hematoma.

In terms of diagnosis & treatment segment, the intracranial hemorrhage diagnosis & treatment market has been divided into diagnosis and treatment. The diagnosis segment has been further divided into CT, MRI, and others. The treatment segment has been further bifurcated into medication and surgery. In terms of medication type, the global market is further classified into anti-hypertensive drugs, coagulants, and others. However, based on surgery, the market is further classified as decompression surgery, craniotomy with open surgery, endoscopic evacuation, stereotactic aspiration, and clipping or coiling procedures.

Regional Analysis
Geographically, the Global Intracranial Hemorrhage Diagnosis & Treatment Market has been segmented into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas is expected to contribute the largest share of the global intracranial hemorrhage diagnosis & treatment market during the review period. The regional market is attributed to the well-established healthcare sector, increased expenditure on research, rapid adoption of advanced treatment, and the presence of leading players in the region.
The European market is anticipated to exhibit the second largest market due to the advanced treatment facilities, rising government initiatives to promote research, rising number of trauma cases, and increasing number healthcare spending. Asia-Pacific is anticipated to register substantial market growth during the review period. The regional market growth is attributed to the rising R&D funding by developing countries such as China and India for the development of the healthcare infrastructure.

Major Players
The Key Players in the Global Intracranial Hemorrhage Diagnosis & Treatment Market include Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Infrascan, inc. (US), Johnson & Johnson (US), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Siemens AG (Germany), Stryker Corporation (US) and Others.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027

Patient Monitoring Devices Market By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices); By End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

The post Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027 first appeared on CRI Report.